KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Change in Receivables (2016 - 2025)

Johnson & Johnson's Change in Receivables history spans 17 years, with the latest figure at -$391.0 million for Q4 2025.

  • For Q4 2025, Change in Receivables rose 54.16% year-over-year to -$391.0 million; the TTM value through Dec 2025 reached $1.8 billion, up 338.67%, while the annual FY2025 figure was $1.8 billion, 338.67% up from the prior year.
  • Change in Receivables for Q4 2025 was -$391.0 million at Johnson & Johnson, down from -$111.0 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $1.6 billion in Q2 2021 and bottomed at -$1.2 billion in Q1 2021.
  • The 5-year median for Change in Receivables is $174.0 million (2021), against an average of $184.1 million.
  • The largest YoY upside for Change in Receivables was 416.67% in 2024 against a maximum downside of 275.77% in 2024.
  • A 5-year view of Change in Receivables shows it stood at $252.0 million in 2021, then surged by 69.44% to $427.0 million in 2022, then plummeted by 153.16% to -$227.0 million in 2023, then plummeted by 275.77% to -$853.0 million in 2024, then soared by 54.16% to -$391.0 million in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Change in Receivables are -$391.0 million (Q4 2025), -$111.0 million (Q3 2025), and $1.4 billion (Q2 2025).